We are currently working to resolve technical issues preventing us from processing applications or payment for membership. Please email Membership on subscriptions@rheumatology.org.uk with any queries.
Search

Overview

BSR's clinical guidelines support evidence-based clinical practice in rheumatology.

Our guidelines grow out of the collaborative efforts of many members and non-members, specialists and generalists, patients and carers.

Firmly embedded in clinical practice – users lead the proposal, selection and development of all guideline topics – we choose new areas, areas where there is clinical uncertainty, where mortality or morbidity can be reduced.

All guidelines are published in Rheumatology journal under an ‘open access’ licence.

Accreditation-logo-resize254x93

NICE accredits our clinical guideline process; this is valid until February 2022.


We want to hear your experiences of using the guidelines to help us spot patterns, create case studies and find solutions to problems.

How has care in your unit improved through implementation? What clinical issues have you resolved by using a guideline? Are you or your unit having problems implementing any part of the guidelines?

If there is anything else you would like to share with us about planning, creating, auditing or using the guidelines, please email guidelines@rheumatology.org.uk.

Current guidelines

Biological DMARD safety Guideline for the safe prescribing of biologics in adults with inflammatory arthritis.
Executive summary
Full guideline
Lupus Guideline for the management of adults with Systemic Lupus Erythematosus. 2017 NICE-accredited. Due for revision 2020
Executive summary
Full guideline
Audit tool
Podcast
Sjögren’s Syndrome Guideline for the management of adults with Primary Sjögren’s Syndrome. 2017 NICE-accredited. Due for revision 2020
Executive summary
Full guideline
Audit tool
Podcast
Gout Guideline for the management of gout. 2017 NICE-accredited. Due for revision 2020.
Executive summary
Full guideline
Audit tool
Podcast
DMARDs Guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. 2017 NICE-accredited. Due for revision 2020.
Executive summary
Full guideline
Audit tool
Podcast
Axial spondyloarthritis Guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. 2016 NICE-accredited. Due for revision 2019.
Executive summary
Full guideline
Audit tool
Podcast
Systemic sclerosis Guideline for the treatment of systemic sclerosis. 2016 NICE-accredited. Due for revision in 2019
Executive summary
Full guideline
Audit (See page 10 of the full GL for guidance on audit)
Podcast
Pregnancy and breastfeeding: Part 1 Guideline on prescribing drugs in pregnancy and breastfeeding Part 1: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. 2016 NICE-accredited. Due for revision in 2019.
Executive summary
Full guideline
Audit tool
Podcast
Pregnancy and breastfeeding: Part 2 Guideline on prescribing drugs in pregnancy and breastfeeding Part 2: analgesics and drugs used in rheumatology practice. 2016 NICE-accredited. Due for revision in 2019.
Executive summary
Full guideline
Audit tool
Podcast
PsA with biologics Guideline for the treatment of psoriatic arthritis with biologics. 2013 NICE-accredited. In revision 2019.
Executive summary
Full guideline
PsA guidelines revision statement
Hot swollen joint Guideline for management of hot swollen joint in adults. Due for revision in 2019.
Executive summary
Full guideline
Hot Joint guideline update
Polymyalgia rheumatica Guideline for the management of polymyalgia rheumatica. The 2009 guideline remains current. It is substantially the same as the 2015 EULAR/ACR guideline: Recommendations for the Management of Polymyalgia Rheumatica. Due for revision in 2019.
Executive summary
Full guideline
ANCA-associated vasculitis Guideline for the management of adults with ANCA-associated vasculitis. In revision 2019.
Executive summary
Full guideline and suggestions for audit

Guidelines in development


Adult patients with idiopathic inflammatory myopathy Management of adult patients with idiopathic inflammatory myopathy (myositis)
Paediatric patients with idiopathic inflammatory myopathy
Management of paediatric patients with idiopathic inflammatory myopathy (myositis)
Foot health in inflammatory arthritis Management of foot health in patients with inflammatory arthritis 

Guidelines under revision


Giant cell arteritis Guideline on the management of patients with giant cell arteritis.

Executive summary
Guideline
Audit tool
PsA with biologics
The treatment of PsA with biologics.

Executive summary
ANCA-associated vasculitis
The management of adults with ANCA associated vasculitis.

Executive summary